冠状动脉支架内再狭窄的研究进展
Research Progress of In-Stent Restenosis of Coronary Arteries
DOI: 10.12677/ACM.2023.135999, PDF,    国家自然科学基金支持
作者: 贾娜尔·阿达力：新疆医科大学第一附属医院心脏中心综合心脏内科，新疆 乌鲁木齐；新疆医科大学第一临床医学院，新疆 乌鲁木齐；张敏钰：新疆医科大学第一临床医学院，新疆 乌鲁木齐；木胡牙提*：新疆医科大学第一附属医院心脏中心综合心脏内科，新疆 乌鲁木齐
关键词: 冠心病；经皮冠状动脉介入术；支架内再狭窄；药物洗脱支架；Coronary Heart Disease (CHD)； Percutaneous Coronary Intervention (PCI)； Stent Restenosis； Drug Eluting Stent (DES)
摘要: 冠心病是心内科的主要疾病之一。现阶段，治疗冠心病的主要方法之一是经皮冠状动脉介入术(PCI)，该方法极大地改善了冠心病患者的预后。但PCI术的支架内再狭窄(ISR)是介入治疗面临的重大难题。本文就PCI术后支架内再狭窄的病理生理机制、危险因素、诊断等方面的最新研究进展作一综述。
Abstract: Coronary heart disease is a common disease in cardiology. At present, percutaneous coronary in-tervention (PCI) is one of the main methods for the treatment of coronary heart disease, which greatly improves the prognosis of patients with coronary heart disease. However, in stent restenosis (ISR) after PCI is an unavoidable complication, which greatly reduces its long-term efficacy and be-comes a major problem for interventional therapy. This article reviews the latest research progress in pathophysiological mechanism, risk factors, predictors, diagnosis and treatment of in stent restenosis after PCI.
文章引用：贾娜尔·阿达力, 张敏钰, 木胡牙提. 冠状动脉支架内再狭窄的研究进展[J]. 临床医学进展, 2023, 13(5): 7151-7156. https://doi.org/10.12677/ACM.2023.135999

参考文献

[1] Wang, Y., Liu, J., Wang, W., et al. (2015) Lifetime Risk for Cardiovascular Disease in a Chinese Population: The Chi-nese Multi-Provincial Cohort Study. European Journal of Preventive Cardiology, 22, 380-388. [Google Scholar] [CrossRef] [PubMed]
[2] Feinberg, J., Nielsen, E.E., Greenhalgh, J., et al. (2017) Drug-Eluting Stents versus Bare-Metal Stents for Acute Coronary Syndrome. Cochrane Database of Systematic Reviews, 8, CD012481. [Google Scholar] [CrossRef] 
[3] Mauri, L., Silbaugh, T.S., Garg, P., et al. (2008) Drug-Eluting or Bare-Metal Stents for Acute Myocardial Infarction. The New England Journal of Medicine, 359, 1330-1342. [Google Scholar] [CrossRef] 
[4] 王振, 徐通达, 李东野. 冠心病合并糖尿病经皮冠状动脉介入治疗术后支架内再狭窄预测因素分析[J]. 安徽医药, 2019, 23(9): 1821-1825. [Google Scholar] [CrossRef] 
[5] Kuntz, R.E. and Baim, D.S. (1993) Defining Coronary Restenosis. Newer Clinical and Angiographic Paradigms. Circulation, 88, 1310-1323. [Google Scholar] [CrossRef] 
[6] 颜安. 中性粒细胞/淋巴细胞比值对冠脉介入术后支架内再狭窄的预测价值分析[D]: [硕士学位论文]. 通辽: 内蒙古民族大学, 2020.
[7] Ma, J., Liu, X., Qiao, L., et al. (2021) Association between Stent Implantation and Progression of Nontarget Lesions in a Rabbit Model of Atherosclerosis. Circulation: Cardiovascular Interventions, 14, e010764. [Google Scholar] [CrossRef] 
[8] Komiyama, H., Takano, M., Hata, N., et al. (2015) Neoatherosclerosis: Coronary Stents Seal Atherosclerotic Lesions but Result in Making a New Problem of Ath-erosclerosis. World Journal of Cardiology, 7, 776-783. [Google Scholar] [CrossRef] [PubMed]
[9] Lee, S.W., Lee, J.Y., Ahn, J.M., et al. (2013) Comparison of Dual versus Triple Antiplatelet Therapy after Drug-Eluting Stent According to Stent Length (from the Pooled Analysis of DECLARE Trials). American Journal of Cardiology, 112, 1738-1744. [Google Scholar] [CrossRef] [PubMed]
[10] Otsuka, F., Finn, A.V., Yazdani, S.K., et al. (2012) The Im-portance of the Endothelium in Atherothrombosis and Coronary Stenting. Nature Reviews Cardiology, 9, 439-453. [Google Scholar] [CrossRef] [PubMed]
[11] Cutlip, D.E., Windecker, S., Mehran, R., et al. (2007) Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions. Circulation, 115, 2344-2351. [Google Scholar] [CrossRef] 
[12] Salfati, E., Nandkeolyar, S., Fortmann, S.P., et al. (2015) Susceptibility Loci for Clinical Coronary Artery Disease and Subclinical Coronary Atherosclerosis throughout the Life-Course. Circulation: Cardiovascular Genetics, 8, 803-811. [Google Scholar] [CrossRef] 
[13] Zhuo, Z.L., Xian, H.P., Long, Y., et al. (2018) Associ-ation between CYP2C19 and ABCB1 Polymorphisms and Clopidogrel Resistance in Clopidogrel-Treated Chinese Pa-tients. The Anatolian Journal of Cardiology, 19, 123-129. [Google Scholar] [CrossRef] 
[14] Zheng, D., Mingyue, Z., Wei, S., et al. (2018) The Inci-dence and Risk Factors of In-Stent Restenosis for Vertebrobasilar Artery Stenting. World Neurosurgery, 110, e937-e941. [Google Scholar] [CrossRef] [PubMed]
[15] 齐静, 邹德玲. 2型糖尿病患者冠状动脉支架内再狭窄的危险因素分析[J]. 医学综述, 2020, 26(16): 3303-3307.
[16] Cassese, S., Byrne, R.A., Tada, T., et al. (2014) Incidence and Predictors of Restenosis after Coronary Stenting in 10004 Patients with Surveillance Angiography. Heart, 100, 153-159. [Google Scholar] [CrossRef] [PubMed]
[17] Shlofmitz, E., Iantorno, M. and Waksman, R. (2019) Restenosis of Drug-Eluting Stents: A New Classification System Based on Disease Mechanism to Guide Treatment and State-of-the-Art Review. Circulation: Cardiovascular Interventions, 12, e007023. [Google Scholar] [CrossRef] 
[18] 黄自明, 郭观华, 彭俊, 等. 置入DES与BMS病人术后支架血栓发生率的差异及其影响因素分析[J]. 中西医结合心脑血管病杂志, 2017, 15(16): 2037-2039. [Google Scholar] [CrossRef] 
[19] Yadav, M., Mintz, G.S., Généreux, P., et al. (2019) The Smoker’s Paradox Revisited: A Patient-Level Pooled Analysis of 18 Randomized Controlled Trials. JACC: Cardiovascular Interventions, 12, 1941-1950. [Google Scholar] [CrossRef] [PubMed]
[20] 翟娜, 张宇静, 王明毅, 等. 药物洗脱支架与裸金属支架治疗无保护左主干病变的效果比较[J]. 中国当代医药, 2015, 22(3): 55-58, 61.
[21] Kastrati, A., Dibra, A., Mehilli, J., et al. (2006) Predictive Factors of Restenosis after Coronary Implantation of Sirolimus- or Paclitaxel-Eluting Stents. Circula-tion, 113, 2293-2300. [Google Scholar] [CrossRef] 
[22] 赵全明. 冠心病患者经皮冠状动脉介入术后支架内再狭窄的认识现状[J]. 心肺血管病杂志, 2017, 36(8): 611-612, 620. [Google Scholar] [CrossRef] 
[23] Shlofmitz, E., Kuku, K.O., Waksman, R. and Gar-cia-Garcia, H.M. (2019) Intravascular Ultrasound-Guided Drug-Eluting Stent Implantation. Minerva Cardioangiologica, 67, 306-317. [Google Scholar] [CrossRef] 
[24] Ullrich, H., Olschewski, M., Münzel, T. and Gori, T. (2021) Coronary In-Stent Restenosis: Predictors and Treatment. Deutsches Ärzteblatt International, 118, 637-644. [Google Scholar] [CrossRef] [PubMed]
[25] Araki, M., Park, S.J., Dauerman, H.L., Uemura, S., Kim, J.S., Di Mario, C., et al. (2022) Optical Coherence Tomography in Coronary Atherosclerosis Assessment and Interven-tion. Nature Reviews Cardiology, 19, 684-703. [Google Scholar] [CrossRef] [PubMed]
[26] Jones, D.A., Rathod, K.S., Koganti, S., Hamshere, S., Astrou-lakis, Z., Lim, P., et al. (2018) Angiography Alone versus Angiography plus Optical Coherence Tomography to Guide Percutaneous Coronary Intervention: Outcomes from the Pan-London PCI Cohort. JACC: Cardiovascular Interventions, 11, 1313-1321. [Google Scholar] [CrossRef] [PubMed]
[27] Nerlekar, N., Cheshire, C.J., Verma, K.P., et al. (2017) Intravascu-lar Ultrasound Guidance Improves Clinical Outcomes during Implantation of both First- and Second-Generation Drug-Eluting Stents: A Meta-Analysis. EuroIntervention, 12, 1632-1642. [Google Scholar] [CrossRef] 

为你推荐